Biofrontera Inc. financial data

Symbol
BFRI, BFRIW on Nasdaq
Industry
Pharmaceutical Preparations
Location
120 Presidential Way,, Suite 330, Woburn, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % -0.26%
Quick Ratio 54 % +15.7%
Debt-to-equity 463 % +96.5%
Return On Equity -325 % -49.9%
Return On Assets -55.5 % +14.1%
Operating Margin -54.8 % +24.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.75M shares +411%
Common Stock, Shares, Outstanding 6.53M shares +377%
Entity Public Float 14.2M USD -59.9%
Common Stock, Value, Issued 7K USD +600%
Weighted Average Number of Shares Outstanding, Basic 5.77M shares +322%
Weighted Average Number of Shares Outstanding, Diluted 5.77M shares +322%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 35.4M USD +5.16%
Research and Development Expense 669K USD +1927%
Operating Income (Loss) -19.4M USD +20.7%
Nonoperating Income (Expense) 6.55M USD +59%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.8M USD +51.5%
Income Tax Expense (Benefit) 18K USD +200%
Net Income (Loss) Attributable to Parent -12.8M USD +51.5%
Earnings Per Share, Basic 0.54 USD/shares +78.9%
Earnings Per Share, Diluted 0.54 USD/shares +78.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.87M USD -16%
Accounts Receivable, after Allowance for Credit Loss, Current 3.75M USD -0.95%
Inventory, Net 6.53M USD -59.4%
Assets, Current 16.9M USD -42.8%
Property, Plant and Equipment, Net 82K USD -46.8%
Operating Lease, Right-of-Use Asset 1.08M USD -4.25%
Intangible Assets, Net (Excluding Goodwill) 39K USD -98.6%
Assets 18.5M USD -45.7%
Accounts Payable, Current 1.24M USD +33.5%
Employee-related Liabilities, Current 2.57M USD -12.8%
Accrued Liabilities, Current 4.66M USD -57.8%
Liabilities, Current 11M USD -62.1%
Operating Lease, Liability, Noncurrent 324K USD -42.3%
Other Liabilities, Noncurrent 29K USD -23.7%
Liabilities 13M USD -60.7%
Retained Earnings (Accumulated Deficit) -116M USD -12.4%
Stockholders' Equity Attributable to Parent 5.53M USD +433%
Liabilities and Equity 18.5M USD -45.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.33M USD +9.87%
Net Cash Provided by (Used in) Financing Activities 5.8M USD
Net Cash Provided by (Used in) Investing Activities -14K USD -180%
Common Stock, Shares Authorized 35M shares +133%
Common Stock, Shares, Issued 6.53M shares +377%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.47M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.07M USD -15.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.17M USD
Deferred Tax Assets, Valuation Allowance 42.5M USD +17.6%
Deferred Tax Assets, Gross 42.5M USD +17.6%
Operating Lease, Liability 994K USD -11%
Depreciation 21K USD -4.55%
Payments to Acquire Property, Plant, and Equipment 57K USD +307%
Lessee, Operating Lease, Liability, to be Paid 1.07M USD -10.6%
Property, Plant and Equipment, Gross 691K USD -2.81%
Operating Lease, Liability, Current 670K USD +20.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 246K USD -37.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 590K USD +1.03%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +15.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 72K USD -5.26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 37K USD -15.9%
Deferred Tax Assets, Operating Loss Carryforwards 37M USD +21.4%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 20M shares -0.11%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 31K USD
Additional Paid in Capital 122M USD +16.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 420K USD +0.48%
Interest Expense 2.23M USD +55575%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%